CN Energy Group Inc. Stock Slides After Nasdaq Delisting Notice Over Bid Price Rule 
Goldman Sachs CEO David Solomon’s 2025 Pay Soars to $47 Million After Strong Deal-Making Year 
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas 
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
Microsoft Restores Microsoft 365 Services After Widespread Outage 
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification 
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 
NEW YORK, May 05, 2017 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Amyris, Inc. securities (NASDAQ:AMRS) from March 2, 2017 through April 17, 2017, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Amyris investors under the federal securities laws.
To join the Amyris class action, go to http://www.rosenlegal.com/cases-1104.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) in the first quarter of 2017, Amyris made a decision to take an equity stake in one of Blue California’s affiliates that focused on the sweetener market in lieu of cash payment under the license agreement; (2) consequently, due to Amyris’ decision, Amyris would be unable to recognize $10 million in fourth quarter and fiscal year 2016 revenue from the license agreement with Blue California; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 19, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1104.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com
